Empowering Exosomes with Aptamers for Precision Theranostics
Small Methods · 2025
DOI: 10.1002/smtd.202400551 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Small Methods, 2025. Verfasst von Liyan Zheng und 6 weiteren Autor:innen. Beteiligte Einrichtung: Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, Zhejiang, 310022, China. Hauptthemen laut MEDLINE: Exosomes, Aptamers, Nucleotide, Theranostic Nanomedicine, Precision Medicine. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 241 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Pioneer Research and Development Program of Zhejiang.
Abstract (Originalsprache)
As information messengers for cell‐to‐cell communication, exosomes, typically small membrane vesicles (30–150 nm), play an imperative role in the physiological and pathological processes of living systems. Accumulating studies have demonstrated that exosomes are potential biological candidates for theranostics, including liquid biopsy‐based diagnosis and drug delivery. However, their clinical applications are hindered by several issues, especially their unspecific detection and insufficient targeting ability. How to upgrade the accuracy of exosome‐based theranostics is being widely explored. Aptamers, benefitting from their admirable characteristics, are used as excellent molecular recognition elements to empower exosomes for precision theranostics. With high affinity against targets and easy site‐specific modification, aptamers can be incorporated with platforms for the specific detection of exosomes, thus providing opportunities for advancing disease diagnostics. Furthermore, aptamers can be tailored and functionalized on exosomes to enable targeted therapeutics. Herein, this review emphasizes the empowering of exosomes by aptamers for precision theranostics. A brief introduction of exosomes and aptamers is provided, followed by a discussion of recent progress in aptamer‐based exosome detection for disease diagnosis, and the emerging applications of aptamer‐functionalized exosomes for targeted therapeutics. Finally, current challenges and opportunities in this research field are presented.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, Zhejiang, 310022, China.
- Molecular Science and Biomedicine Laboratory (MBL), State Key Laboratory of Chemo/ Biosensing and Chemometrics, College of Biology, College of Chemistry and Chemical Engineering, Aptamer Engineering Center of Hunan Prov…
- School of Molecular Medicine, Hangzhou Institute for Advanced Study, University of Chinese Academy of Sciences, Hangzhou, Zhejiang, 310024, China.
- Institute of Molecular Medicine (IMM), Renji Hospital, Shanghai Jiao Tong University School of Medicine, and College of Chemistry and Chemical Engineering, Shanghai Jiao Tong University, Shanghai, 200240, China.
ORCID-Profile: Weihong Tan
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
- Pioneer Research and Development Program of Zhejiang
- Natural Science Foundation of Shandong Province
- Taishan Scholar Foundation of Shandong Province
- Science and Technology Major Project of Hunan Province
- Zhejiang Provincial Health Commission Research Foundation
Zitieren
APA
Zheng, L., Li, J., Li, Y., Sun, W., Ma, L., Qu, F., & Tan, W. (2025). Empowering Exosomes with Aptamers for Precision Theranostics. Small Methods. https://doi.org/10.1002/smtd.202400551
Vancouver
Zheng L, Li J, Li Y, Sun W, Ma L, Qu F, et al. Empowering Exosomes with Aptamers for Precision Theranostics. Small Methods. 2025. doi:10.1002/smtd.202400551
BibTeX
@article{Zheng2025,
author = {Zheng, Liyan and Li, Jin and Li, Yingying and Sun, Weidi and Ma, LeLe and Qu, Fengli and Tan, Weihong},
title = {Empowering Exosomes with Aptamers for Precision Theranostics},
journal = {Small Methods},
year = {2025},
doi = {10.1002/smtd.202400551}
}
EUVIMED